
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeut... Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.87 | -1.61860465116 | 53.75 | 54.52 | 52.64 | 1401942 | 53.50590717 | CS |
4 | -0.35 | -0.657523952658 | 53.23 | 56.39 | 52.64 | 1685317 | 54.21205456 | CS |
12 | -11.47 | -17.8243978244 | 64.35 | 70.505 | 47.5 | 2249953 | 57.32539053 | CS |
26 | 5.24 | 10.9991603694 | 47.64 | 70.505 | 46.26 | 1794487 | 57.17212727 | CS |
52 | 2.77 | 5.52783875474 | 50.11 | 70.505 | 42.01 | 1627258 | 55.57835206 | CS |
156 | 8.17 | 18.2733169313 | 44.71 | 70.505 | 29.85 | 1355483 | 47.43367461 | CS |
260 | 28.08 | 113.225806452 | 24.8 | 70.505 | 24.3617 | 1261167 | 44.23888076 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.